{"id":8084,"date":"2023-11-27T15:29:02","date_gmt":"2023-11-27T20:29:02","guid":{"rendered":"https:\/\/mitocanada.org\/traitements-finances-par-les-provinces\/"},"modified":"2024-12-05T16:46:56","modified_gmt":"2024-12-05T21:46:56","slug":"traitements-finances-par-les-provinces","status":"publish","type":"page","link":"https:\/\/mitocanada.org\/fr\/traitements-finances-par-les-provinces\/","title":{"rendered":"Traitements financ\u00e9s par les provinces"},"content":{"rendered":"<div class=\"fusion-fullwidth fullwidth-box fusion-builder-row-1 fusion-flex-container nonhundred-percent-fullwidth non-hundred-percent-height-scrolling\" style=\"--awb-border-radius-top-left:0px;--awb-border-radius-top-right:0px;--awb-border-radius-bottom-right:0px;--awb-border-radius-bottom-left:0px;--awb-flex-wrap:wrap;\" ><div class=\"fusion-builder-row fusion-row fusion-flex-align-items-flex-start fusion-flex-content-wrap\" style=\"max-width:1456px;margin-left: calc(-4% \/ 2 );margin-right: calc(-4% \/ 2 );\"><div class=\"fusion-layout-column fusion_builder_column fusion-builder-column-0 fusion_builder_column_1_1 1_1 fusion-flex-column\" style=\"--awb-bg-size:cover;--awb-width-large:100%;--awb-margin-top-large:0px;--awb-spacing-right-large:1.92%;--awb-margin-bottom-large:0px;--awb-spacing-left-large:1.92%;--awb-width-medium:100%;--awb-spacing-right-medium:1.92%;--awb-spacing-left-medium:1.92%;--awb-width-small:100%;--awb-spacing-right-small:1.92%;--awb-spacing-left-small:1.92%;\"><div class=\"fusion-column-wrapper fusion-flex-justify-content-flex-start fusion-content-layout-column\"><div class=\"fusion-text fusion-text-1\"><div data-hveid=\"CBIQAQ\">\n<div class=\"dnXCYb\" tabindex=\"0\" role=\"button\" aria-controls=\"_MTQ1ZfKYFInI0PEPuaGx6A8_29\" aria-expanded=\"true\">\n<h3 class=\"L3Ezfd\" data-ved=\"2ahUKEwiy9Zad8YmCAxUJJDQIHblQDP0Quk56BAgSEAI\">Dans cette section, MitoCanada fournira des informations sur l&rsquo;acc\u00e8s aux m\u00e9dicaments concernant les nouvelles th\u00e9rapies disponibles pour les maladies mitochondriales.<\/h3>\n<\/div>\n<\/div>\n<\/div><div class=\"fusion-separator fusion-full-width-sep\" style=\"align-self: center;margin-left: auto;margin-right: auto;margin-top:25px;width:100%;\"><\/div><div ><a class=\"fusion-button button-flat fusion-button-default-size button-default fusion-button-default button-1 fusion-button-default-span fusion-button-default-type\" target=\"_self\" href=\"https:\/\/mitocanada.org\/about-us\/dojolvi\/\"><span class=\"fusion-button-text\">Ultragenyx &#8211; Triheptanoin (DOJOLVI)<\/span><\/a><\/div><\/div><\/div><\/div><\/div>\n","protected":false},"excerpt":{"rendered":"","protected":false},"author":2,"featured_media":0,"parent":0,"menu_order":0,"comment_status":"closed","ping_status":"closed","template":"","meta":{"om_disable_all_campaigns":false,"_monsterinsights_skip_tracking":false,"_monsterinsights_sitenote_active":false,"_monsterinsights_sitenote_note":"","_monsterinsights_sitenote_category":0,"_uf_show_specific_survey":0,"_uf_disable_surveys":false,"footnotes":""},"class_list":["post-8084","page","type-page","status-publish","hentry"],"aioseo_notices":[],"_links":{"self":[{"href":"https:\/\/mitocanada.org\/fr\/wp-json\/wp\/v2\/pages\/8084","targetHints":{"allow":["GET"]}}],"collection":[{"href":"https:\/\/mitocanada.org\/fr\/wp-json\/wp\/v2\/pages"}],"about":[{"href":"https:\/\/mitocanada.org\/fr\/wp-json\/wp\/v2\/types\/page"}],"author":[{"embeddable":true,"href":"https:\/\/mitocanada.org\/fr\/wp-json\/wp\/v2\/users\/2"}],"replies":[{"embeddable":true,"href":"https:\/\/mitocanada.org\/fr\/wp-json\/wp\/v2\/comments?post=8084"}],"version-history":[{"count":2,"href":"https:\/\/mitocanada.org\/fr\/wp-json\/wp\/v2\/pages\/8084\/revisions"}],"predecessor-version":[{"id":8086,"href":"https:\/\/mitocanada.org\/fr\/wp-json\/wp\/v2\/pages\/8084\/revisions\/8086"}],"wp:attachment":[{"href":"https:\/\/mitocanada.org\/fr\/wp-json\/wp\/v2\/media?parent=8084"}],"curies":[{"name":"wp","href":"https:\/\/api.w.org\/{rel}","templated":true}]}}